Changes in thrombus composition and profilin-1 release in acute myocardial infarction

European Heart Journal

Volumn 36, Issue 16, 2015, Pages 965-975

  Ramaiola, Ilaria ^a   Padró, Teresa ^a   Peña, Esther ^a   Juan Babot, Oriol ^a   Cubedo, Judit ^a   Martin Yuste, Victoria ^b   Sabate, Manel ^b   Badimon, Lina ^a,c  

^a Institut Català de Ciències Cardiovasculars   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Occlusive thrombus ageing; PCI; Platelets; Profilin 1

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ACTIN; CLOPIDOGREL; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; PROFILIN; PROFILIN 1; PROTEOME; TROPOMYOSIN; TROPOMYOSIN 3; TROPOMYOSIN 4; UNCLASSIFIED DRUG; ANTITHROMBOCYTIC AGENT; THROMBIN; TICLOPIDINE;

ARTICLE; B LYMPHOCYTE; BLOOD CLOTTING; CELL INFILTRATION; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY THROMBOSIS; CYTOSKELETON; DIAGNOSTIC TEST ACCURACY STUDY; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MONOCYTE; NEUTROPHIL; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL CIRCULATION; PLASMA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; PROTEOMICS; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL; SYSTEMIC CIRCULATION; T LYMPHOCYTE; THORAX PAIN; THROMBECTOMY; THROMBECTOMY CATHETER; THROMBOCYTE; ANALOGS AND DERIVATIVES; ANALYSIS OF VARIANCE; CORONARY THROMBOSIS; FEMALE; MALE; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SECRETION (PROCESS); THROMBOCYTE AGGREGATION; TIME TO TREATMENT;

ANALYSIS OF VARIANCE; BLOOD PLATELETS; CORONARY THROMBOSIS; FEMALE; FIBRINOGEN; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PROFILINS; THROMBECTOMY; THROMBIN; TICLOPIDINE; TIME-TO-TREATMENT;

EID: 84928380778     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu356     Document Type: Article

References (43)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 1992;326:310-318.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 1992;326:242-250.
3. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045-1057.
4. Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG, Cornel JH, Bhatt DL, Clemmensen P, Martinez F, Ardissino D, Nicolau JC, Boden WE, Gurbel PA, Ruzyllo W, Dalby AJ, McGuire DK, Leiva-Pons JL, Parkhomenko A, Gottlieb S, Topacio GO, Hamm C, Pavlides G, Goudev AR, Oto A, Tseng CD, Merkely B, Gasparovic V, Corbalan R, Cinteza M, McLendon RC, Winters KJ, Brown EB, Lokhnygina Y, Aylward PE, Huber K, Hochman JS, Ohman EM. Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 2012;367:1297-1309.
5. Antman EM, Wiviott SD, Murphy SA, Voitk J, Hasin Y, Widimsky P, Chandna H, MaciasW, McCabe CH, Braunwald E. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis. J Am Coll Cardiol 2008;51:2028-2033.
6. Badimon L, Chesebro JH, Badimon JJ. Thrombus formation on ruptured atherosclerotic plaques and rethrombosis on evolving thrombi. Circulation 1992;86:(6 Suppl): III74-III85.
7. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995;92:657-671.
8. Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013;34:719-728.
9. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev 2007;21:99-111.
10. Wohner N. Role of cellular elements in thrombus formation and dissolution. Cardiovasc Hematol Agent Med Chem 2008;6:224-228.
11. Vilahur G, Segales E, Salas E, Badimon L. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow-and lesiondependent thrombosis in the porcine ex vivo model. Circulation 2004;110: 1686-1693.
12. Virmani R, Ladich ER, BurkeAP, Kolodgie FD. Histopathology of carotid atherosclerotic disease. Neurosurgery 2006;59:(5 Suppl. 3):S219-S227; discussion S213-213.
13. Shenkman B, Livnat T, Lubetsky A, Tamarin I, Budnik I, Einav Y, Martinowitz U. The in vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model. Blood Coagul Fibrinol 2012;23:370-378.
14. Sartori M, Conti E, Favaretto E, Frascaro M, Legnani C, Palareti G. Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease. Eur J Vasc Endovasc Surg 2011;42:817-823.
15. Kramer MC, Rittersma SZ, de Winter RJ, Ladich ER, Fowler DR, Liang YH, Kutys R, Carter-Monroe N, Kolodgie FD, van derWal AC, Virmani R. Relationship of thrombus healing to underlying plaque morphology in sudden coronary death. J Am Coll Cardiol 2010;55:122-132.
16. Silvain J, Collet JP, Nagaswami C, Beygui F, Edmondson KE, Bellemain-Appaix A, Cayla G, Pena A, Brugier D, Barthelemy O, Montalescot G,WeiselJW. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol 2011;57: 1359-1367.
17. Yunoki K, NarukoT, Sugioka K, Inaba M, IwasaY, Komatsu R, Itoh A, Haze K, Inoue T, Yoshiyama M, Becker AE, Ueda M. Erythrocyte-rich thrombus aspirated from patients with ST-elevation myocardial infarction: association with oxidative stress and its impact on myocardial reperfusion. Eur Heart J 2012;33:1480-1490.
18. Kramer MC, van der Wal AC, Koch KT, Ploegmakers JP, van der Schaaf RJ, Henriques JP, Baan J Jr, Rittersma SZ, Vis MM, Piek JJ, Tijssen JG, de Winter RJ. Presence of older thrombus is an independent predictor of long-term mortality in patients with ST-elevation myocardial infarction treated with thrombus aspiration during primary percutaneous coronary intervention. Circulation 2008;118: 1810-1816.
19. Barba I, Garcia del Blanco B, Abdul-Jawad O, Barrabes JA, Marti G, Domingo E, Angel J, Garcia-Dorado D. MRI discriminates thrombus composition and ST resolution after percutaneous coronary intervention in patients with ST-elevation myocardial infarction. PloS One 2011;6:e18459.
20. Iwata H, Sata M, Ando J, Fujita H, Morita T, Sawaki D, Takahashi M, Hirata Y, Takanashi S, Tabata M, Hirata Y, Nagai R. Impact of primitive cells in intracoronary thrombi on lesion prognosis: temporal analysis of cellular constituents of thrombotic material obtained from patients with acute coronary syndrome. Heart 2010;96: 748-755.
21. Cubedo J, Ramaiola I, Padro T, Martin-Yuste V, Sabate-Tenas M, Badimon L. Highmolecular weight kininogen and the intrinsic coagulation pathway in patients with de novo acute myocardial infarction. Thromb Haemost 2013;110:1121-1134.
22. Peña E, Padro T, Molins B, Vilahur G, Badimon L. Proteomic signature of thrombin-activated platelets after in vivo nitric oxide-donor treatment: coordinated inhibition of signaling (phosphatidylinositol 3-kinase-{gamma}, 14-3-3{zeta}, and growth factor receptor-bound protein 2) and cytoskeleton protein translocation. Arteriosc Thromb Vasc Biol 2011;31:2560-2569.
23. Peña E, Arderiu G, Badimon L. Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration. J Thromb Haemost 2012;10: 2373-2382.
24. Caglayan E, Romeo GR, Kappert K, OdenthalM, Sudkamp M, Body SC, Shernan SK, Hackbusch D, Vantler M, Kazlauskas A, Rosenkranz S. Profilin-1 is expressed in human atherosclerotic plaques and induces atherogenic effects on vascular smooth muscle cells. PloS One 2010;5:e13608.
25. Cheng JF,NiGH,ChenMF, Li YJ,Wang YJ,Wang CL, Yuan Q, Shi RZ,HuCP, Yang TL. Involvement of profilin-1 in angiotensin II-induced vascular smooth muscle cell proliferation. Vasc Pharmacol 2011;55:34-41.
26. Toth O, Calatzis A, Penz S, Losonczy H, SiessW. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006; 96:781-788.
27. Silva-Orrego P, Colombo P, Bigi R, Gregori D, Delgado A, Salvade P, Oreglia J, Orrico P, de Biase A, Piccalo G, Bossi I, Klugmann S. Thrombus aspiration before primary angioplasty improves myocardial reperfusion in acute myocardial infarction: the DEAR-MI (Dethrombosis to Enhance Acute Reperfusion in Myocardial Infarction) study. J Am Coll Cardiol 2006;48:1552-1559.
28. Burzotta F, De Vita M, Gu YL, Isshiki T, Lefevre T, Kaltoft A, Dudek D, Sardella G, Orrego PS, Antoniucci D, De Luca L, Biondi-Zoccai GG, Crea F, Zijlstra F. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J 2009;30:2193-2203.
29. De Luca G, Dudek D, Sardella G, Marino P, Chevalier B, Zijlstra F. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur Heart J 2008;29:3002-3010.
30. Romeo GR, Moulton KS, Kazlauskas A. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse. Circul Res 2007; 101:357-367.
31. Elnakish MT, Hassanain HH, Janssen PM. Vascular remodeling-associated hypertension leads to left ventricular hypertrophy and contractile dysfunction in profilin-1 transgenic mice. J Cardiovasc Pharmacol 2012;60:544-552.
32. Bae YH, Ding Z, Das T,Wells A, Gertler F, Roy P. Profilin1 regulates PI(3,4)P2 and lamellipodin accumulation at the leading edge thus influencing motility of MDA-MB-231 cells. Proc Natl Acad Sci USA 2010;107:21547-21552.
33. Yun SP, Ryu JM, Jang MW, Han HJ. Interaction of profilin-1 and F-actin via a beta-arrestin-1/JNK signaling pathway involved in prostaglandin E(2)-induced human mesenchymal stem cells migration and proliferation. J Cell Physiol 2011;226:559-571.
34. Yarmola EG, Bubb MR. How depolymerization can promote polymerization: the case of actin and profilin. Bioessays 2009;31:1150-1160.
35. Yarmola EG, Bubb MR. Profilin: emerging concepts and lingering misconceptions. Trend Biochem Sci 2006;31:197-205.
36. Volpi E, Giusti L, Ciregia F, Da Valle Y, Giannaccini G, Berti S, Clerico A, Lucacchini A. Platelet proteome and clopidogrel response in patients with stable angina undergoing percutaneous coronary intervention. Clin Biochem 2012;45:758-765.
37. Hartwig JH, Chambers KA, Hopcia KL, Kwiatkowski DJ. Association of profilin with filament-free regions of human leukocyte and platelet membranes and reversible membrane binding during platelet activation. J Cell Biol 1989;109:(4 Pt 1): 1571-1579.
38. Kasina S,Wasia R, Fasim A, Radhika KV, Singh SS. Phorbol ester mediated activation of inducible nitric oxide synthase results in platelet profilin nitration. Nitric Oxide 2006;14:65-71.
39. Goldschmidt-Clermont PJ, Machesky LM, Doberstein SK, PollardTD. Mechanism of the interaction of human platelet profilin with actin. J Cell Biol 1991;113:1081-1089.
40. Piersma SR, Broxterman HJ, Kapci M, de Haas RR, Hoekman K, Verheul HM, Jimenez CR. Proteomics of the TRAP-induced platelet releasate. J Proteom 2009; 72:91-109.
41. Badimon JJ, Lettino M, Toschi V, Fuster V, Berrozpe M, Chesebro JH, Badimon L. Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions. Circulation 1999;99:1780-1787.
42. Toschi V, Gallo R, Lettino M, Fallon JT, Gertz SD, Fernandez-Ortiz A, Chesebro JH, Badimon L, Nemerson Y, Fuster V, Badimon JJ. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation 1997;95: 594-599.
43. Rittersma SZ, van derWalAC,KochKT, Piek JJ,Henriques JP,Mulder KJ,Ploegmakers JP, MeestermanM, deWinter RJ. Plaque instability frequentlyoccurs days orweeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 2005;111:1160-1165.